BREAKING
Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 14 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 14 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago
ADVERTISEMENT
Analysis

CannTrust may be cheap, but stay away from this pot stock

Shares of CannTrust Holdings (NYSE: CTST) have plunged over 80% in the past 12 months, making it quite cheap with respect to its cannabis growing potential. It might look like an irresistible offer at this price, for a marijuana stock that comes with immense growth potential. Yet, it’s safe to stay clear. If you have […]

September 13, 2019 2 min read

Shares of CannTrust Holdings (NYSE: CTST)
have plunged over 80% in the past 12 months, making it quite cheap with respect
to its cannabis growing potential. It might look like an irresistible offer at
this price, for a marijuana stock that comes with immense growth potential. Yet,
it’s safe to stay clear.

If you have not been following the stock, the logic wouldn’t strike you too quickly. The Ontario-based company has been embroiled in two major scandals recently, making it quite difficult to convince investors that it is a credible firm.

Canopy Growth Co-CEO Bruce Linton exits
Image by Rex Medlen from Pixabay

The first was in July when it was discovered that CannTrust illegally grew marijuana in rooms hidden behind walls, besides exporting some of this to countries such as Denmark. Worse, the management allegedly knew about these wrongdoings but remained silent about it.

CannTrust had fired its CEO Peter Aceto following the
incident.

Regulators are yet to announce a punishment, which could be anywhere between cutting down its inventory to scrapping its license. Though a takeover could put a gradual end to CannTrust’s woes, uncertainty surrounding the penalty faced by the company makes it an unattractive takeover target.  

ADVERTISEMENT

READ: Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0

Even if a potential buyer comes forward, it will be tasked with the cumbersome job of convincing the regulators that its practices would change following the merger.

Amidst all this, CannTrust once again came under the hammer after the Ontario Cannabis Store returned about $3 million worth of its products for not conforming to the supplier agreement.  This double whammy almost wipes of CannTrust’s credibility and makes regaining investor confidence a major hurdle.

On a whole, pot stocks may not be performing as one might have expected. Yet, when so many credible firms are out in the market, it makes little sense to try CannTrust even at the given valuation.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT